Silence Therapeutics Plc ADR is a biotechnology company focused on developing RNA-based medicines that use short interfering RNA, or siRNA, to regulate the activity of specific genes. Silence Therapeutics Plc ADR is working across hematology, cardiovascular disease, and rare diseases, with a pipeline that includes candidates designed to address blood disorders, complement-mediated renal conditions, and lipid-related cardiovascular conditions. The company’s research and development activities center on discovering and delivering novel RNA therapeutics that can silence disease-driving targets inside cells. Through its current product candidates and platform-driven approach, Silence Therapeutics Plc ADR plays a specialized role in the growing field of genetic medicine, where precision therapies are being developed for conditions with limited treatment options. The company is headquartered in London, United Kingdom.
Website72 Hammersmith Road
London, W14 8TH
United Kingdom
What share of all stock conversation is about SLN?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0.01% new | 0% +0 | 0% 0 | 0% +0 |
Of the messages about SLN that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% | 100% 0 | 36.95% -62.54 | 72.74% -9.91 | ||
| Bearish | 0% | 0% 0 | 63.05% +62.54 | 27.26% +9.91 |
Of the messages about SLN that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | — | 40% | 86.55% | ||
| Technical Analysis | — | — | 60% | 11.43% | ||
| Analysts | — | — | 0% | 1.79% | ||
| Controversies | — | — | 0% | 0% | ||
| Earnings | — | — | 0% | 0.22% | ||
| Macro | — | — | 0% | 0% |
Of the messages about SLN, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 0% | 0% | 11.24% | 17.56% | ||
| Newcomers | 100% | 100% | 88.76% | 82.44% |
Investors talking about SLN also mention